Se espera que el tamaño del mercado de antibióticos basados en carbapenémicos crezca de US$ 3.964,57 millones en 2021 a US$ 5.346,62 millones en 2028; se estima que crecerá a una CAGR del 4,4% durante 2021-2028.
Los carbapenémicos son un tipo de antibióticos β-lactámicos atípicos que tienen una actividad antibacteriana más amplia. Los antibióticos basados en carbapenémicos pueden cubrir muchas bacterias grampositivas, gramnegativas, aerobias y anaerobias. Además, los antibióticos basados en carbapenémicos son estables a la mayoría de las β-lactamasas. Por lo tanto, están indicados como monoterapia empírica para varias afecciones graves, como infecciones neutropénicas e infecciones intraabdominales.
La creciente prevalencia de infecciones bacterianas gramnegativas y la creciente producción de medicamentos genéricos impulsan el crecimiento del mercado de antibióticos basados en carbapenémicos . Sin embargo, el tedioso y costoso proceso de desarrollo de antibióticos frena el crecimiento del mercado.
Personalice este informe según sus necesidades
Obtendrá personalización en cualquier informe, sin cargo, incluidas partes de este informe o análisis a nivel de país, paquete de datos de Excel, así como también grandes ofertas y descuentos para empresas emergentes y universidades.
Mercado de antibióticos a base de carbapenémicos: perspectivas estratégicas
- Obtenga las principales tendencias clave del mercado de este informe.Esta muestra GRATUITA incluirá análisis de datos, desde tendencias del mercado hasta estimaciones y pronósticos.
Perspectivas de mercado:
aumento de la prevalencia de infecciones bacterianas gramnegativas
Las infecciones bacterianas gramnegativas, como la infección del tracto urinario (ITU), la neumonía, las infecciones del torrente sanguíneo, las infecciones de heridas o del sitio quirúrgico y la meningitis, son comúnmente adquiridas por los pacientes durante sus estadías en el hospital. Estas infecciones generalmente se conocen como infecciones adquiridas en el hospital (IAH). Infecciones como la ITU y la neumonía son comunes en pacientes ingresados en unidades de cuidados intensivos. Según la Red Nacional de Seguridad Sanitaria de EE. UU., el 30 % de las IAH son causadas por bacterias gramnegativas, aproximadamente el 45 % se deben a ITU y aproximadamente el 47 % son por neumonía asociada al respirador (NAV). La prevalencia de enfermedades infecciosas causadas por bacterias gramnegativas está aumentando rápidamente.
Además, las infecciones bacterianas gramnegativas son resistentes a múltiples fármacos y han desarrollado una mayor resistencia a los antibióticos disponibles. La resistencia a los antimicrobianos (RAM) se ha convertido en una amenaza global para la medicina moderna. Por lo tanto, se requiere un seguimiento constante de las tendencias emergentes para los aislamientos clínicos. Un grupo de investigadores de Letonia, Europa, ha estudiado la progresión de la RAM para diferentes bacterias gramnegativas. Según el artículo de investigación publicado por ellos en la revista MDPI en junio de 2021, los antibióticos basados en carbapenémicos, como Meropenem y Ertapenem, fueron los más eficaces contra las bacterias gramnegativas, mostrando tasas de resistencia del 3% y el 5,4%, respectivamente. Estos antibióticos son aceptados mundialmente como tratamiento para las bacterias gramnegativas. Por lo tanto, se estima que es probable que la alta demanda de antibióticos basados en carbapenémicos continúe en los próximos años.AMR) has become a global threat to modern medicine. Therefore, constant monitoring of emerging trends is required for the clinical isolates. A group of researchers in Latvia, Europe, has studied the progression of AMR for different gram-negative bacteria. As per the research article published by them in the MDPI journal in June 2021, carbapenem-based antibiotics such as Meropenem and Ertapenem were the most effective against gram-negative bacteria, showing 3% and 5.4% resistance rates, respectively. These antibiotics are globally accepted as a treatment for gram-negative bacteria. Therefore, it is estimated that the high demand for carbapenem-based antibiotics is likely to continue in the coming years.
Según los Centros para el Control y la Prevención de Enfermedades (CDC), la pandemia de COVID-19 provocó un aumento de los casos de HAI en 2020. Las admisiones hospitalarias han aumentado a nivel mundial, lo que ha aumentado el riesgo de VAP como infección secundaria para los pacientes con COVID-19. Esto ha provocado un aumento de la demanda de antibióticos a base de carbapenémicos, lo que está ayudando significativamente al mercado.HAI cases in 2020. Hospital admissions have grown globally, which has increased the risk of VAP as a secondary infection for COVID-19 patients. This has resulted in fueled demand for carbapenem-based antibiotics, which is aiding the market significantly.
Perspectivas basadas en tipos
El mercado de antibióticos a base de carbapenem, por tipo, está segmentado en meropenem, doripenem, imipenem, tebipenem y otros. El segmento de otros tuvo la mayor participación del mercado de antibióticos a base de carbapenem en 2021, y se prevé que registre la CAGR más alta del mercado durante el período de pronóstico. Es probable que los crecientes desarrollos de antibióticos a base de carbapenem impulsen el crecimiento del mercado en el futuro.carbapenem-based antibiotics market, by type, is segmented into meropenem, doripenem, imipenem, tebipenem, and others. The others segment held the largest share of the carbapenem-based antibiotics market in 2021, and it is anticipated to register the highest CAGR in the market during the forecast period. The growing developments for carbapenem-based antibiotics are likely to drive the market growth in the future.
Perspectivas basadas en indicaciones
Según los datos, el mercado de antibióticos a base de carbapenémicos se segmenta en meningitis bacteriana, infecciones pélvicas agudas, infecciones del tracto respiratorio , infecciones intraabdominales, infecciones del tracto urinario y otras. El segmento Otros tuvo la mayor participación del mercado de antibióticos a base de carbapenémicos en 2021, y se estima que registrará la CAGR más alta del mercado durante el período de pronóstico. La incertidumbre de las infecciones bacterianas impulsa la demanda de antibióticos a base de carbapenémicos, lo que se espera que impulse el crecimiento del mercado en los próximos años.carbapenem-based antibiotics market is segmented into bacterial meningitis, acute pelvic infections, intra-abdominal infections, carbapenem-based antibiotics market in 2021, and it is estimated to register the highest CAGR in the market during the forecast period. The uncertainty of bacterial infections propels the demand for carbapenem-based antibiotics, which is expected to drive the growth of market in the coming years.
Perspectivas regionales del mercado de antibióticos basados en carbapenémicos
Los analistas de Insight Partners explicaron en detalle las tendencias y los factores regionales que influyen en el mercado de antibióticos a base de carbapenem durante el período de pronóstico. Esta sección también analiza los segmentos y la geografía del mercado de antibióticos a base de carbapenem en América del Norte, Europa, Asia Pacífico, Oriente Medio y África, y América del Sur y Central.
- Obtenga datos regionales específicos para el mercado de antibióticos basados en carbapenémicos
Alcance del informe de mercado sobre antibióticos a base de carbapenémicos
| Atributo del informe | Detalles |
|---|---|
| Tamaño del mercado en 2021 | US$ 3.96 mil millones |
| Tamaño del mercado en 2028 | 5.350 millones de dólares estadounidenses |
| CAGR global (2021-2028) | 4,4% |
| Datos históricos | 2019-2020 |
| Período de pronóstico | 2022-2028 |
| Segmentos cubiertos | Por tipo
|
| Regiones y países cubiertos | América del norte
|
| Líderes del mercado y perfiles de empresas clave |
|
Densidad de actores del mercado de antibióticos a base de carbapenémicos: comprensión de su impacto en la dinámica empresarial
El mercado de antibióticos a base de carbapenémicos está creciendo rápidamente, impulsado por la creciente demanda de los usuarios finales debido a factores como la evolución de las preferencias de los consumidores, los avances tecnológicos y una mayor conciencia de los beneficios del producto. A medida que aumenta la demanda, las empresas amplían sus ofertas, innovan para satisfacer las necesidades de los consumidores y aprovechan las tendencias emergentes, lo que impulsa aún más el crecimiento del mercado.
La densidad de actores del mercado se refiere a la distribución de las empresas o firmas que operan dentro de un mercado o industria en particular. Indica cuántos competidores (actores del mercado) están presentes en un espacio de mercado determinado en relación con su tamaño o valor total de mercado.
Las principales empresas que operan en el mercado de antibióticos basados en carbapenémicos son:
- Pfizer Inc.
- Salvador Lifetec
- Sumitomo Dainippon Pharma Co., Ltd.
- Compañía farmacéutica Merck & Co., Inc.
- Glándula farmacéutica limitada
Descargo de responsabilidad : Las empresas enumeradas anteriormente no están clasificadas en ningún orden particular.
- Obtenga una descripción general de los principales actores clave del mercado de antibióticos basados en carbapenémicos
Información basada en canales de distribución
Por canal de distribución, el mercado de antibióticos a base de carbapenémicos se segmenta en farmacias minoristas, farmacias en línea y farmacias hospitalarias. El segmento de farmacias hospitalarias tuvo la mayor participación del mercado de antibióticos a base de carbapenémicos en 2021, y se estima que registrará la CAGR más alta del mercado durante el período de pronóstico.
Las estrategias orgánicas, como el lanzamiento de nuevos productos, son comúnmente adoptadas por las empresas para expandir sus carteras de productos en el mercado. Además, las empresas han implementado varias estrategias inorgánicas, como fusiones y adquisiciones y asociaciones. Por ejemplo, en mayo de 2021, Gland Pharma Limited, en asociación con Dr Reddy's Laboratories Ltd, lanzó Ertapenem para inyección, 1 g/vial, un equivalente terapéutico a la versión genérica de INVANZ (ertapenem para inyección) para inyección) 1 g/vial, que está aprobado por la Administración de Alimentos y Medicamentos de los Estados Unidos (USFDA).
Perfiles de empresas
- Pfizer Inc.
- Salvador Lifetec
- Sumitomo Dainippon Pharma Co., Ltd.
- Compañía farmacéutica Merck & Co., Inc.
- Glándula farmacéutica limitada
- Aurobindo Pharma Ltd
- Compañía farmacéutica Daewoong Ltd.
- Terapéutica Iterum plc
- ACS Dobfar SpA
- Terapéutica Spero
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The carbapenem-based antibiotics market is analyzed in the basis of type, indication, and distribution channel. Based on type, is segmented into meropenem, doripenem, imipenem, tebipenem, and others. The others segment held the largest share of the market, and it is anticipated to register the highest CAGR. Based indication, the market is segmented as bacterial meningitis, acute pelvic infections, respiratory tract infections, intra-abdominal infections, urinary tract infections, and others. The others segment held the largest share of the market, and it is estimated to register the highest CAGR. And based on distribution channel, the market is divided into retail pharmacies, online pharmacies, and hospital pharmacies. The hospital pharmacies segment held the largest share of the market, and it is estimated to register the highest CAGR.
The carbapenem-based antibiotics market majorly consists of the players such as Pfizer Inc.; Savior Lifetec; Sumitomo Dainippon Pharma Co., Ltd.; Merck & Co., Inc.; Gland Pharma Limited; Aurobindo Pharma Ltd; Daewoong Pharmaceutical Co.,Ltd; Iterum Therapeutics plc; ACS Dobfar S.p.A, and Spero Therapeutics among others.
Carbapenems are type of atypical β-lactam antibiotics that have wider antibacterial activity. Carbapenem-based antibiotics can cover many gram-positive, gram-negative aerobic, anaerobic bacteria. Additionally, carbapenem-based antibiotics are stable to most β-lactamases and hence, are indicated as empiric monotherapy for various serious conditions such as neutropenic infections and intra-abdominal infections.
The factors that are driving the growth of market are growing rising prevalence of gram-negative bacterial infections and increasing production of generic drugs fuel the growth of the market. However, the tedious and expensive process of antibiotic development, as well as approval, is the major factor hindering the market growth.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies - Carbapenem Based Antibiotics Market
- Pfizer Inc.
- Savior Lifetec
- Sumitomo Dainippon Pharma Co., Ltd.
- Merck & Co., Inc.
- Gland Pharma Limited
- Aurobindo Pharma Ltd
- Daewoong Pharmaceutical Co.,Ltd,
- Iterum Therapeutics plc
- ACS Dobfar S.p.A
- Spero Therapeutics
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For